DR. KARTIK KONDURI MD NPI 1417995499

NPI Information

  • NPI: 1417995499
  • Provider Name: DR. KARTIK KONDURI, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3410 WORTH ST
    DALLAS, TX
    ZIP 75246
  • Phone: (214) 370-1000

Map and Directions

Get Directions

NPI Details

DR. Kartik Konduri, MD is a medical oncology internal medicine in Dallas, TX with 33 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Kartik Konduri, MD NPI is 1417995499. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:1993

The provider's business location address is:

3410 WORTH ST
DALLAS, TX
ZIP 75246-003
Phone: (214) 370-1000
Fax: (214) 370-1202

The NPI 1417995499 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Unclassified drugs (HCPCS:J3490)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Albumin (protein) level (HCPCS:82040)
  • Bilirubin level, total (HCPCS:82247)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Total protein level, blood (HCPCS:84155)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 6/3/2006 and was last updated on 11/30/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyL3363TEXASNo
2207RX0202XInternal MedicineMedical OncologyL3363TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1078671702MEDICAIDTEXAS
2078671704MEDICAIDTEXAS
38R1489OTHERTEXASBLUE CROSS OF TX
4078671703MEDICAIDTEXAS
5078671706MEDICAIDTEXAS
6078671705MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.